Dianthus Therapeutics, Inc. (DNTH)
105.61
-0.23
(-0.22%)
USD |
NASDAQ |
Aug 31, 16:00
105.75
+0.14
(+0.13%)
Pre-Market: 08:23
Dianthus Therapeutics Cash from Operations (Annual) : -129.06M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -129.06M |
| December 31, 2024 | -78.18M |
| December 31, 2023 | -36.86M |
| December 31, 2022 | -29.07M |
| December 31, 2021 | -59.53M |
| Date | Value |
|---|---|
| December 31, 2020 | -64.02M |
| December 31, 2019 | -57.10M |
| December 31, 2018 | -41.89M |
| December 31, 2017 | -22.26M |
| December 31, 2016 | -6.529M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Legend Biotech Corp. | -100.46M |
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Verastem, Inc. | -137.51M |
| Fortress Biotech, Inc. | -71.34M |
| AbbVie, Inc. | 19.03B |